Renal sarcoidosis

被引:0
作者
Marta Calatroni
Gabriella Moroni
Francesco Reggiani
Claudio Ponticelli
机构
[1] Humanitas University,Department of Biomedical Sciences
[2] IRCCS Humanitas Research Hospital,Nephrology and Dialysis Division
[3] Independent Researcher,undefined
来源
Journal of Nephrology | 2023年 / 36卷
关键词
Renal sarcoidosis; Noncaseating granulomas; Granulomatous interstitial nephritis; Hypercalcemia; Acute kidney injury; End-stage kidney disease;
D O I
暂无
中图分类号
学科分类号
摘要
Sarcoidosis is a systemic inflammatory disease of unknown etiology. The pathogenesis rests on an aberrant T cell response to unidentified antigens in individuals predisposed by genetic and environmental factors. Increased expression of polarized macrophages and disequilibrium between effector and regulator T cells contribute to the formation of noncaseating granulomas, that are frequently found in affected organs. The main kidney abnormalities in sarcoidosis are granulomatous interstitial nephritis (GIN) and hypercalcemia-related disorders. The clinical diagnosis is difficult. The outcome is variable, ranging from spontaneous remission to end-stage kidney disease (ESKD). Early diagnosis and prompt treatment with corticosteroids can improve the prognosis. Hypercalcemia may be responsible for acute kidney injury (AKI) caused by vasoconstriction of afferent arterioles. Complications of persistent hypercalcemia include nephrocalcinosis and renal stones. In patients with ESKD, dialysis and transplantation can offer results comparable to those observed in patients with other causes of kidney failure. Based on a review of the literature, we present an overview of the etiopathogenesis, the renal manifestations of sarcoidosis and their complications, management and prognosis.
引用
收藏
页码:5 / 15
页数:10
相关论文
共 488 条
[1]  
Larsson J(2020)Sarcoidosis and increased risk of comorbidities and mortality in Sweden Sarcoidosis Vasc Diffuse Lung Dis 37 104-135
[2]  
Graff P(2020)Sarcoidosis epidemiology: race matters Front Immunol 11 527-534
[3]  
Bryngelsson IL(2021)Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up Respir Med 187 158-67
[4]  
Vihlborg P(2020)Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors Curr Opin Pulm Med 26 61-388
[5]  
Hena KM(2018)Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study Respir Res 19 380-596
[6]  
Sikjær MG(1995)The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study Sarcoidosis 12 585-520
[7]  
Hilberg O(2020)Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences Clin Exp Rheumatol 34 513-447
[8]  
Ibsen R(2020)Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet Respir Med 8 439-436
[9]  
Løkke A(2018)Renal sarcoidosis: approach to diagnosis and management Curr Opin Pulm Med 24 165-553
[10]  
Arkema EV(2021)Drug-induced sarcoidosis-like reactions Curr Opin Pulm Med 27 427-41